134 related articles for article (PubMed ID: 38062660)
1. The Dosage Recommendation of Cyclosporin in Children with Hemophagocytic Lymphohistiocytosis based on Population Pharmacokinetic Model.
Yang Y; Li YF; Hu K; Zhang SJ; Cui JF; Huang XT; He SM; Wang DD; Chen X
Curr Pharm Des; 2023; 29(37):2996-3004. PubMed ID: 38062660
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics and initial dosing regimen optimization of cyclosporin in pediatric hemophagocytic lymphohistiocytosis patients.
Wang DD; Ye QF; Chen X; Xu H; Li ZP
Xenobiotica; 2020 Apr; 50(4):435-441. PubMed ID: 31382792
[TBL] [Abstract][Full Text] [Related]
3. Onset of Hemophagocytic Lymphohistiocytosis during Piperacillin-Tazobactam Therapy in Three Children with Acute Focal Bacterial Nephritis.
Miyabayashi H; Kumaki S; Sato A; Onuma R; Noguchi R; Sato T; Metoki T; Watanabe Y; Tazawa Y; Imaizumi M; Kitaoka S
Tohoku J Exp Med; 2018 May; 245(1):55-59. PubMed ID: 29798969
[TBL] [Abstract][Full Text] [Related]
4. Treatment of pediatric primary hemophagocytic lymphohistiocytosis with the HLH-94/2004 regimens and hematopoietic stem cell transplantation in China.
Ma H; Zhang R; Zhang L; Wei A; Zhao X; Yang Y; Liu W; Li Z; Qin M; Wang T
Ann Hematol; 2020 Oct; 99(10):2255-2263. PubMed ID: 32766934
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of continuous infusion of piperacillin/tazobactam in very elderly hospitalized patients and considerations for target attainment against Enterobacterales and Pseudomonas aeruginosa.
Cojutti PG; Morandin E; Baraldo M; Pea F
Int J Antimicrob Agents; 2021 Oct; 58(4):106408. PubMed ID: 34314808
[TBL] [Abstract][Full Text] [Related]
6. Drug-Induced Hypersensitivity Syndrome With Hemophagocytic Lymphohistiocytosis Related to Piperacillin-Tazobactam: A Case Report.
Shen Y; Teng X; Zha L; Han M; Wang Q
J Investig Allergol Clin Immunol; 2023 Dec; 33(6):493-495. PubMed ID: 36988092
[No Abstract] [Full Text] [Related]
7. Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis.
Thompson PA; Allen CE; Horton T; Jones JY; Vinks AA; McClain KL
Pediatr Blood Cancer; 2009 May; 52(5):621-5. PubMed ID: 19137570
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing and treating hemophagocytic lymphohistiocytosis in the tropics: systematic review from the Indian subcontinent.
Rajagopala S; Singh N
Acta Med Acad; 2012; 41(2):161-74. PubMed ID: 23331391
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Drug Monitoring and Pharmacokinetic Analysis of Cyclosporine in a Pediatric Patient with Hemophagocytic Lymphohistiocytosis Complicated by Diabetes Insipidus: A Grand Round.
Liang Y; Wu Z; Zhao L; Wu J; Chen X; Tang W; Zeng J
Ther Drug Monit; 2021 Jun; 43(3):303-306. PubMed ID: 33560100
[TBL] [Abstract][Full Text] [Related]
10. Profile of hemophagocytic lymphohistiocytosis; efficacy of intravenous immunoglobulin therapy.
Rajajee S; Ashok I; Manwani N; Rajkumar J; Gowrishankar K; Subbiah E
Indian J Pediatr; 2014 Dec; 81(12):1337-41. PubMed ID: 24806152
[TBL] [Abstract][Full Text] [Related]
11. Drug reaction with eosinophilia and systemic symptoms (DRESS)-associated hemophagocytic lymphohistiocytosis (HLH), an important and underrecognized HLH mimic: A case report.
Carter Febres M; Abbott J; Cipriano SD; Knackstedt ED; George TI; Afify Z
Pediatr Blood Cancer; 2021 Feb; 68(2):e28657. PubMed ID: 32808435
[No Abstract] [Full Text] [Related]
12. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Spironolactone Co-administration on Cyclosporin Initial Dosage Optimization for Pediatric Refractory Nephrotic Syndrome.
Han HH; Rui M; Yang Y; Cui JF; Huang XT; Zhang SJ; He SM; Wang DD; Chen X
Curr Pharm Des; 2024 Apr; ():. PubMed ID: 38639271
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and outcomes of patients with hemophagocytic lymphohistiocytosis at onset of systemic autoinflammatory disorder and compare with Epstein-Barr virus (EBV)-related hemophagocytic lymphohistiocytosis.
Zhao Y; Li Z; Zhang L; Lian H; Ma H; Wang D; Zhao X; Zhang Q; Wang T; Zhang R
Medicine (Baltimore); 2020 Jan; 99(1):e18503. PubMed ID: 31895784
[TBL] [Abstract][Full Text] [Related]
15. Outcome analysis of pediatric hemophagocytic lymphohistiocytosis.
Chen TY; Hsu MH; Kuo HC; Sheen JM; Cheng MC; Lin YJ
J Formos Med Assoc; 2021 Jan; 120(1 Pt 1):172-179. PubMed ID: 32307323
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of piperacillin/tazobactam in critically ill young children.
Cies JJ; Shankar V; Schlichting C; Kuti JL
Pediatr Infect Dis J; 2014 Feb; 33(2):168-73. PubMed ID: 23907263
[TBL] [Abstract][Full Text] [Related]
17. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: A retrospective multicenter study.
Xu XJ; Wang HS; Ju XL; Xiao PF; Xiao Y; Xue HM; Shi HY; Gao YJ; Jia GC; Li XR; Zhao WH; Wang NL; Tang YM;
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27781387
[TBL] [Abstract][Full Text] [Related]
19. Continuous infusion of piperacillin-tazobactam significantly improves target attainment in children with cancer and fever.
Maarbjerg SF; Thorsted A; Friberg LE; Nielsen EI; Wang M; Schrøder H; Albertsen BK
Cancer Rep (Hoboken); 2022 Oct; 5(10):e1585. PubMed ID: 34796702
[TBL] [Abstract][Full Text] [Related]
20. Hemophagocytic lymphohistiocytosis complicating invasive pneumococcal disease: a pediatric case report.
Tsuge M; Miyamoto M; Miyawaki R; Kondo Y; Tsukahara H
BMC Pediatr; 2020 Jan; 20(1):15. PubMed ID: 31931763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
